Core Viewpoint - China Dongfang (01763) announced that its subsidiary, Shenzhen Zhongke Haidewei Biotechnology Co., Ltd., has successfully been selected as a national-level manufacturing enterprise and awarded the "Pharmaceutical Industry Single Champion" for its core product, the "Urea [C/C] Breath Test Kit" [1] Company Summary - The company focuses on the application of medical isotopes in the niche market of Urea [13C] and [14C] breath diagnostics [1] - The Urea [13C] and [14C] breath test products are used for detecting Helicobacter pylori [1] - The products cover over 20,000 end customers domestically and are sold to 90 countries and regions [1] - The market share has consistently ranked among the top in the industry for several years [1]

Core Viewpoint - China Tongru (01763.HK) announced that its subsidiary, Shenzhen Zhongke Haidewei Biotechnology Co., Ltd., has successfully been selected as a national-level manufacturing enterprise and awarded the "Single Champion in the Pharmaceutical Industry" for its core product, the "Urea [C/C] Breath Test Kit" [1] Company Summary - China Tongru focuses on the application of medical isotopes in the urea [C] and [C] breath diagnostic niche, producing products used for detecting Helicobacter pylori [1] - The company's urea [C] and [C] breath test products cover over 20,000 end customers in China and are sold to 90 countries and regions, maintaining a leading market share in the industry for several consecutive years [1] Industry Summary - The company aims to further strengthen its position in technological innovation, continuously delve into breath diagnostics and related fields, and develop more advanced products and solutions to meet clinical needs, contributing to the health defense of the population [1]